Bristol Myers Squibb‘s experimental cell therapy arlocabtagene autoleucel (arlo-cel) may help control myeloma that has returned or failed…

A CAR T-cell therapy targeting glioblastoma improved tumor control and survival in mice when given before surgery rather than afterward, according to a new study.

September is Gynecologic Cancer Awareness Month, and advocacy groups are running campaigns to raise awareness about gynecological cancers, raise funds for research, and…